Maury Raycroft
Stock Analyst at Jefferies
(4.48)
# 1,115
Out of 5,023 analysts
241
Total ratings
42.6%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio | Reiterated: Buy | $29 | $8.23 | +252.37% | 2 | Oct 1, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $56 → $112 | $94.45 | +18.58% | 5 | Sep 28, 2026 | |
| ANL Adlai Nortye Group | Initiated Coverage: Buy | $31 | $15.09 | +105.43% | 1 | Sep 10, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $77 → $28 | $15.22 | +83.97% | 16 | Sep 3, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $47 → $10 | $1.89 | +429.10% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $44 → $42 | $20.43 | +105.58% | 7 | Aug 5, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterated: Buy | $35 → $11 | $0.8022 | +1,271.23% | 7 | Jul 31, 2026 | |
| ERAS Erasca | Rated: Buy | $21 → $24 | $14.74 | +62.82% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $39 → $47 | $31.19 | +50.69% | 3 | Jul 13, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $27 → $60 | $23.24 | +158.18% | 3 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $88.21 | +49.64% | 6 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $33 | $6.13 | +438.34% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.38 | +255.03% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $0.8567 | +950.54% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $52 | $37.36 | +39.19% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $5.74 | +161.32% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $1.94 | +1,343.30% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $4.01 | +398.75% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $15.83 | +32.66% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.56 | +2.56% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $549 | $219.72 | +149.86% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $8.17 | +83.60% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $24.50 | +67.35% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $56.93 | n/a | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $79 | $72.10 | n/a | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $23 | $12.21 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $1.12 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.63 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $9 | $2.98 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $15 | $6.85 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.5 | $0.1475 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3798 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.02 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $0.0002 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $25.57 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.8112 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $30.42 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $64.19 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $55.43 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.7873 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $109 | $12.26 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $25 | $9.48 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $86 | $24.33 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.31 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $38.02 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.03 | n/a | 2 | May 22, 2018 |
Q32 Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.23
Upside: +252.37%
Kodiak Sciences
Sep 28, 2026
Rated: Buy
Price Target: $56 → $112
Current: $94.45
Upside: +18.58%
Adlai Nortye Group
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $15.09
Upside: +105.43%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $77 → $28
Current: $15.22
Upside: +83.97%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $47 → $10
Current: $1.89
Upside: +429.10%
Tyra Biosciences
Aug 5, 2026
Reiterated: Buy
Price Target: $44 → $42
Current: $20.43
Upside: +105.58%
Karyopharm Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $35 → $11
Current: $0.8022
Upside: +1,271.23%
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $14.74
Upside: +62.82%
Hemab Therapeutics Holdings
Jul 13, 2026
Reiterated: Buy
Price Target: $39 → $47
Current: $31.19
Upside: +50.69%
Tango Therapeutics
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $23.24
Upside: +158.18%
Jun 15, 2026
Reiterated: Buy
Price Target: $132
Current: $88.21
Upside: +49.64%
May 12, 2026
Reiterated: Buy
Price Target: $53 → $33
Current: $6.13
Upside: +438.34%
Apr 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.38
Upside: +255.03%
Apr 27, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $0.8567
Upside: +950.54%
Apr 5, 2026
Reiterated: Buy
Price Target: $14 → $52
Current: $37.36
Upside: +39.19%
Mar 23, 2026
Reiterated: Buy
Price Target: $14 → $15
Current: $5.74
Upside: +161.32%
Feb 25, 2026
Reiterated: Buy
Price Target: $28
Current: $1.94
Upside: +1,343.30%
Dec 8, 2025
Reiterated: Buy
Price Target: $15 → $20
Current: $4.01
Upside: +398.75%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $15.83
Upside: +32.66%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.56
Upside: +2.56%
Oct 30, 2025
Reiterated: Buy
Price Target: $384 → $549
Current: $219.72
Upside: +149.86%
Oct 14, 2025
Reiterated: Buy
Price Target: $14 → $15
Current: $8.17
Upside: +83.60%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $24.50
Upside: +67.35%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $56.93
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $33 → $79
Current: $72.10
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40 → $23
Current: $12.21
Upside: n/a
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $1.12
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $8
Current: $4.63
Upside: n/a
May 19, 2025
Reiterated: Buy
Price Target: $15 → $9
Current: $2.98
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $7 → $15
Current: $6.85
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $2 → $1.5
Current: $0.1475
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3798
Upside: n/a
Nov 13, 2024
Rated: Buy
Price Target: $21
Current: $1.02
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $10 → $20
Current: $0.0002
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $25.57
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.8112
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $30.42
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $75
Current: $64.19
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $55.43
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.7873
Upside: n/a
Jun 22, 2021
Reiterated: Buy
Price Target: $37 → $109
Current: $12.26
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $14 → $25
Current: $9.48
Upside: n/a
Jul 29, 2020
Reiterated: Buy
Price Target: $34 → $86
Current: $24.33
Upside: n/a
May 18, 2020
Reiterated: Buy
Price Target: $25
Current: $6.31
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $38.02
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $5.03
Upside: n/a